Cellebrite CLBT
$10.77 −$0.55 (-4.86%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $11.23 +4.27%
Open$11.18
Prev close$11.32
Day range$10.72 – $11.41
Volume2.71M
Market cap$2.71B
P/E (TTM)43.1
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$149.02M+18.2% YoY
Operating profit$26.88M+41.5% YoY
Net profit$26.66M+32.0% YoY
Diluted EPS$0.10+25.0% YoY
Free cash flow$43.33M+44.7% YoY
Operating cash flow$56.58M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin82.3%
Operating margin11.9%
Net margin12.0%
Return on equity12.6%
Return on assets6.8%
Return on invested capital9.3%
Current ratio1.66
Liabilities / assets45.8%
Cash & investments$483.87M
Total debt$17.24M
Net cash (debt)$466.63M
Free cash flow / sales26.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $149.02M | $131.14M | $128.30M | $475.68M | $128.82M |
| Total Operating Revenue | $149.02M | $131.14M | $128.30M | $475.68M | $128.82M |
| Cost of Revenue | $27.98M | $25.21M | $22.42M | $75.17M | $19.69M |
| Gross Profit | $121.05M | $105.93M | $105.88M | $400.50M | $109.13M |
| Operating Expense | $94.17M | $98.98M | $96.76M | $334.02M | $88.33M |
| Selling and Admin Expenses | $57.79M | $63.02M | $60.89M | $220.15M | $58.46M |
| -Selling & Marketing Expense | $36.83M | $43.75M | $43.22M | $154.81M | $38.56M |
| -General & Admin Expense | $20.95M | $19.27M | $17.67M | $65.33M | $19.90M |
| Research & Development | $36.39M | $35.96M | $35.87M | $113.88M | $29.87M |
| Operating Profit | $26.88M | $6.95M | $9.12M | $66.48M | $20.81M |
| Net Non-Operating Interest Income (Expense) | $4.87M | $4.24M | $4.52M | $23.46M | $4.73M |
| Non-Operating Interest Income | $4.87M | $4.24M | – | $23.94M | $5.21M |
| Pretax Profit | $31.74M | $11.19M | $13.63M | $90.68M | $26.27M |
| Tax | $5.09M | $4.82M | $2.70M | $12.35M | $5.01M |
| Net Profit | $26.66M | $6.37M | $10.94M | $78.33M | $21.26M |
| Profit from Continuing Operations | $26.66M | $6.37M | $10.94M | $78.33M | $21.26M |
| Net Income to Parent Company | $26.66M | $6.37M | $10.94M | $78.33M | $21.26M |
| Net Income to Common Stockholders | $26.66M | $6.37M | $10.94M | $77.81M | $20.75M |
| Basic EPS | $0.11 | $0.03 | $0.04 | $0.32 | $0.09 |
| Diluted EPS | $0.10 | $0.02 | $0.04 | $0.31 | $0.08 |
| Total Other Finance Costs | – | – | -$4.52M | -$41,000.00 | $18.69M |
| Non-Operating Interest Expense | – | – | – | $523,000.00 | – |
| Other Income (Expense) | – | – | – | $737,000.00 | – |
| Gain on Sale of Security | – | – | – | $737,000.00 | – |
| Other Preferred Stock Dividends | – | – | – | $513,000.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.07B | $994.31M | $952.29M | $938.85M | $938.85M |
| Total Current Assets | $658.41M | $589.68M | $540.87M | $575.85M | $575.85M |
| Cash and Cash Equivalents & Short-Term Investments | $483.87M | $442.53M | $429.07M | $437.05M | $437.05M |
| -Cash and Cash Equivalents | $223.06M | $141.25M | $133.69M | $124.46M | $124.46M |
| -Short Term Investments | $260.81M | $301.28M | $295.38M | $312.59M | $312.59M |
| Receivables | $139.82M | $110.78M | $72.74M | $104.97M | $104.97M |
| -Accounts Receivable | $139.82M | $110.78M | $72.74M | $104.97M | $104.97M |
| Inventory | $7.51M | $8.39M | $7.53M | $7.60M | $7.60M |
| Current Deferred Assets | $5.84M | $6.47M | $5.73M | $6.60M | $6.60M |
| Other Current Assets | $21.38M | $21.51M | $25.80M | $4.46M | $4.46M |
| Total Non-Current Assets | $410.07M | $404.63M | $411.42M | $363.00M | $363.00M |
| Net PPE | $43.58M | $40.97M | $39.55M | $38.52M | $38.52M |
| -Gross PPE | $43.58M | $40.97M | $39.55M | $83.27M | $83.27M |
| Investments and Advances | $109.41M | $103.19M | $105.49M | $97.96M | $97.96M |
| -Available for Sale Securities | $109.41M | $103.19M | $105.49M | $97.96M | $97.96M |
| Goodwill and Other Intangible Assets | $237.49M | $241.47M | $247.53M | $201.03M | $201.03M |
| -Goodwill | $119.56M | $119.56M | $119.56M | $119.56M | $119.56M |
| -Other Intangible Assets | $117.93M | $121.91M | $127.97M | $81.47M | $81.47M |
| Non-Current Deferred Assets | $11.79M | $11.67M | $11.76M | $10.88M | $10.88M |
| Other Non-Current Assets | $7.80M | $7.34M | $7.09M | $14.62M | $14.62M |
| Total Liabilities | $489.18M | $456.21M | $441.75M | $454.53M | $454.53M |
| Total Current Liabilities | $395.45M | $364.21M | $350.21M | $369.66M | $369.66M |
| Payables | $93.82M | $95.12M | $90.52M | $29.58M | $29.58M |
| -Accounts Payable | $20.47M | $18.11M | $10.87M | $16.83M | $16.83M |
| -Other Payable | $73.35M | $77.01M | $79.65M | $6.59M | $6.59M |
| Short-Term Debt and Capital Lease Obligation | $6.12M | $5.74M | $4.60M | $4.00M | $4.00M |
| -Current Capital Lease Obligation | $6.12M | $5.74M | $4.60M | $4.00M | $4.00M |
| Current Deferred Liabilities | $295.51M | $263.35M | $255.10M | $278.24M | $278.24M |
| Total Non-Current Liabilities | $93.73M | $92.01M | $91.54M | $84.88M | $84.88M |
| Long Term Debt and Capital Lease Obligation | $17.24M | $17.49M | $18.21M | $18.67M | $18.67M |
| -Long Term Capital Lease Obligation | $17.24M | $17.49M | $18.21M | $18.67M | $18.67M |
| Non-Current Deferred Liabilities | $51.07M | $49.94M | $50.15M | $49.53M | $49.53M |
| Other Non-Current Liabilities | $25.42M | $24.57M | $23.18M | $16.68M | $16.68M |
| Total Equity | $579.31M | $538.10M | $510.54M | $484.32M | $484.32M |
| Stockholders' Equity | $579.31M | $538.10M | $510.54M | $484.32M | $484.32M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $622.77M | $605.81M | $585.23M | $568.72M | $568.72M |
| Retained Earnings | -$42.57M | -$69.23M | -$75.60M | -$86.54M | -$86.54M |
| Less: Treasury Stock | -$85,000.00 | -$85,000.00 | -$85,000.00 | -$85,000.00 | -$85,000.00 |
| Gains/Losses Not Affecting Retained Earnings | -$804,000.00 | $1.60M | $992,000.00 | $2.22M | $2.22M |
| Prepaid Assets | – | – | – | $13.15M | $13.15M |
| -Accumulated Depreciation | – | – | – | -$44.75M | -$44.75M |
| -Total Tax Payable | – | – | – | $6.16M | $6.16M |
| Current Accrued Expenses | – | – | – | $57.84M | $57.84M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $56.58M | $17.59M | $19.89M | $173.54M | $86.81M |
| Net cash flow from continuing operations | $56.58M | $17.59M | $19.89M | $173.54M | $86.81M |
| Net Income from Continuing Operations | $26.66M | $6.37M | $10.94M | $78.33M | $21.26M |
| Depreciation & Depletion & Amortization | $9.34M | $8.92M | $7.01M | $11.87M | $3.94M |
| Deferred Tax | $70,000.00 | -$15,000.00 | -$750,000.00 | $75,000.00 | $1.90M |
| Other Non-Cash Items | -$1.84M | -$1.74M | -$1.79M | -$8.16M | -$1.75M |
| Change in Working Capital | $7.65M | -$10.96M | -$8.75M | $46.61M | $47.30M |
| -Change in Receivables | -$29.13M | -$38.07M | $32.44M | -$15.78M | $4.65M |
| -Change in Inventory | $878,000.00 | -$859,000.00 | $144,000.00 | $1.63M | $1.28M |
| -Change in Prepaid Assets | $810,000.00 | $4.35M | -$4.96M | $5.61M | $2.55M |
| -Change in Payables and Accrued Expense | $910,000.00 | $14.08M | -$16.38M | $9.19M | $12.25M |
| -Change in Other Current Assets | -$459,000.00 | $805,000.00 | $1.61M | -$2.35M | -$3.74M |
| -Change in Other Current Liabilities | $38,000.00 | $749,000.00 | -$738,000.00 | -$1.47M | $579,000.00 |
| -Change In Other Working Capital | $34.60M | $7.99M | -$20.86M | $49.77M | $29.73M |
| Net cash flow from investing | $22.39M | -$13.75M | -$13.58M | -$268.25M | -$246.11M |
| Net Cash Flow from Continuing Investing Activities | $22.39M | -$13.75M | -$13.58M | -$268.25M | -$246.11M |
| Net PPE Purchase and Sale | -$4.78M | -$3.07M | -$3.04M | -$13.23M | -$3.96M |
| Net Intangibles Purchase and Sale | -$8.47M | -$8.56M | -$7.06M | $0.00 | $0.00 |
| Net Business Purchase and Sale | $0.00 | $0.00 | -$15.28M | -$147.46M | -$147.46M |
| Net Investment Purchase and Sale | $35.64M | -$2.12M | $11.80M | -$107.57M | -$94.70M |
| Financing Cash Flow | $2.62M | $3.61M | $3.51M | $25.05M | $2.34M |
| Net Cash Flow from Continuing Financing Activities | $2.62M | $3.61M | $3.51M | $25.05M | $2.34M |
| Proceeds from Stock Option Exercised | $2.62M | $3.61M | $3.51M | $25.05M | $2.34M |
| Ending Cash Balance | $223.06M | $141.25M | $133.69M | $124.46M | $124.46M |
| Net Change in Cash | $81.59M | $7.45M | $9.82M | -$69.65M | -$156.96M |
| Beginning Cash Balance | $141.25M | $133.69M | $124.46M | $191.66M | $281.36M |
| Effect of Exchange Rate Changes | $217,000.00 | $110,000.00 | -$589,000.00 | $2.45M | $56,000.00 |
| Free Cash Flow | $43.33M | $5.96M | $9.79M | $160.32M | $82.86M |
| Gain/Loss from Continuing Operations | – | – | – | $2.31M | – |
No comments yet — be the first to weigh in on CLBT.
Sign in to join the discussion.